Dexmedetomidine for Laryngeal Mask Airway Insertion

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators attempted to determine the optimal dose of dexmedetomidine required for the successful insertion of LMA during propofol induction without a neuromuscular blocking agent.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine
• Treatments: Dexmedetomidine; Propofol

Criteria

Inclusion Criteria:

• ASA I-II patients undergoing general anesthesia for short elective surgery (<1 hr)

Exclusion Criteria:

• G-E reflux

• obesity (BMI>30)

• anticipated difficult airway